Reviewed by RC Nelson, health and wellness writer. Last updated July 2026.
Quick Answer
Embody at a glance (July 2026):
- Pricing: compounded semaglutide injections from $79/mo, tirzepatide from $129/mo (Summer Start promo; promotional starting rates that rise with dose and plan length)
- Visit type: async only, no video required
- Insurance: cash-pay, HSA/FSA accepted
- Included: a personalized metabolic report, 1:1 specialist guidance, and care through the OpenLoop Health clinician network
- Best for: first-time GLP-1 users who want a low entry price and a metabolic baseline
- Watch out for: the $79 and $129 rates are promotional, so confirm your maintenance-dose cost before you commit
See Embody's current pricing or compare every vetted telehealth provider.
Key Takeaways
- Embody's Summer Start promotion starts compounded semaglutide injections at $79/mo and tirzepatide at $129/mo, roughly $200 off the standard intro
- Those are promotional starting rates. The ongoing price depends on plan length and the dose you land on
- Every plan includes a personalized metabolic report and 1:1 specialist guidance
- Care runs through the OpenLoop Health network of US-licensed clinicians
- HSA/FSA cards are accepted. Embody does not bill insurance
- Compounded semaglutide and tirzepatide only, and compounded drugs are not FDA-approved as finished products
- Available in all 50 states
I've been tracking compounded GLP-1 pricing for about a year, and Embody's number made me look twice this month. Seventy-nine dollars to start compounded semaglutide. That is lower than GobyMeds, which has held the budget crown at $99 for a while. So is Embody actually the cheapest way to start, or is $79 a hook that quietly climbs once you are on a real dose? The honest answer is that it depends entirely on where your maintenance dose lands, and Embody is upfront that the promo rate is a starting point. Here is what you get for $79, what changes after the promo, and who should care.
What Is Embody
Embody is a telehealth platform that prescribes compounded GLP-1 medications for weight loss. You fill out an intake, a licensed clinician reviews it, and if you are approved, your medication ships to your door. No video visit, no pharmacy runs.
Two things make it worth a closer look. The first is that low Summer Start price. The second is what comes bundled with it: a personalized metabolic report that gives you a baseline before you start, plus 1:1 specialist guidance and 24/7 access to the care team. The clinicians who write your prescription come through OpenLoop Health, a network of US-licensed providers that a lot of telehealth brands quietly run on.
Pricing, and the Catch
As of July 2026, Embody advertises compounded semaglutide injections starting at $79 per month and compounded tirzepatide starting at $129 per month under its Summer Start promotion. These are promotional starting rates. The ongoing price depends on plan length and the dose you settle on, and the advertised rate rises from that $79 starting point as your treatment continues.
That range is the whole story. Here is how the starting price stacks up:
| Provider | Starting price | Medication |
|---|---|---|
| Embody | $79/mo (Summer Start, promotional) | Compounded semaglutide, tirzepatide |
| GobyMeds | $99/mo (steady) | Compounded semaglutide |
| Henry Meds | $149/mo | Compounded semaglutide, tirzepatide |
| Hims | $199/mo | Brand-name semaglutide (Wegovy) |
On the entry price alone, Embody undercuts everyone here. The catch is the word promotional. GobyMeds' $99 is its standard rate with free consultations and free shipping, so it holds steady as you go. Embody's $79 is an introductory number that rises with dose and plan length. If you already know you are heading for a higher maintenance dose, do the math on the ongoing cost before the promo pulls you in. If you are testing the waters, $79 with a metabolic report is a genuinely low-risk way to find out whether GLP-1 treatment works for your body.
What You Actually Get
The metabolic report is the part I would not skip past. Most budget providers hand you medication and a portal login. Embody gives you a baseline read on your metabolism before treatment starts, which is useful context when you are deciding whether the scale is moving because of the drug, your habits, or both.
HSA and FSA cards are accepted, which matters more than it sounds. A $79 starting price paid with pre-tax dollars is effectively cheaper still, and it is one of the few line items in GLP-1 shopping where you can legitimately trim the cost without switching providers. Embody does not bill insurance directly, so if your plan already covers brand-name Wegovy or Zepbound, going through insurance may still beat any cash-pay program, Embody included. Check that first.
Medications
Embody prescribes compounded semaglutide and compounded tirzepatide, both as injections. Semaglutide is the active ingredient in Ozempic and Wegovy. Tirzepatide is the dual-action ingredient in Mounjaro and Zepbound. Both are prepared by licensed compounding pharmacies rather than a brand manufacturer.
One thing to be clear about: compounded medications are not FDA-approved as finished products. They use FDA-approved active ingredients, but the compounded version itself has not gone through the FDA's finished-drug review. If you specifically want brand-name Wegovy or Zepbound, Embody is not your platform. Look at Ro or Eden for brand-name access.
On trust signals, Embody displays a LegitScript certification seal on its site, which is a third-party check that an online pharmacy or telehealth service meets licensing and safety standards. It is worth confirming the seal yourself on the provider's page before you sign up, the same way you would for any cash-pay telehealth brand.
How It Works
- Complete an online health questionnaire. Weight, medical history, current medications, goals. Standard intake.
- A licensed clinician reviews it. Through the OpenLoop Health network. Async, so no scheduled video call.
- Medication ships with your plan. You get the medication, a personalized plan, and your metabolic report at your door. Shipping is free.
- Ongoing support. 1:1 guidance and 24/7 access to the care team for as long as you are on the program.
The Pros
The entry price is real. Seventy-nine dollars for compounded semaglutide plus a metabolic report is one of the lowest starting points in the category right now.
HSA/FSA accepted. A rare place to shave cost with pre-tax dollars.
The metabolic report adds context. A baseline most budget providers skip.
All 50 states. No coverage gaps, no waitlist by geography.
The Cons
The promo is a starting rate. Your maintenance cost can climb with dose and plan length. Confirm your number before you commit.
Compounded only. No brand-name Wegovy, Ozempic, or Zepbound.
Newer platform. Embody does not have the track record of a Hims or a Ro. Not a red flag on its own, but worth weighing.
Who Embody Is Best For
Embody makes the most sense for a first-time GLP-1 user who wants to start cheap and see a metabolic baseline before committing to a maintenance-dose budget. The $79 Summer Start plus HSA/FSA eligibility is about as low-risk an on-ramp as the compounded market offers right now.
It is a weaker fit if you already know you will be on a higher dose long term, or if predictable, flat pricing matters more to you than a low starting price. In that case a steady $99 at GobyMeds, or a same-price-at-every-dose model like Eden's, may cost less over a year even though the starting price is higher.
The Bottom Line
Embody's pitch changed this summer, and for the better. The old hook was a niche one. The new hook is simply price. Seventy-nine dollars to start compounded semaglutide, $129 for tirzepatide, a metabolic report in the box, and HSA/FSA accepted. If you are a first-timer, that is a strong, low-commitment way in.
Just read the word promotional the way Embody means it. The $79 is where you start, not where you stay. Do the maintenance-dose math before the starting price makes the decision for you.
As of July 2026, GLP1 Clinics does not earn a commission from Embody; the link below goes directly to Embody's website. It does not change what you pay or how we score providers.
Ready to compare your options? Compare active providers.
Frequently Asked Questions
How much does Embody cost? As of July 2026, Embody advertises compounded semaglutide injections starting at $79 per month and compounded tirzepatide starting at $129 per month under its Summer Start promotion. These are promotional starting rates; ongoing price depends on plan length and dose selected at checkout.
What medications does Embody offer? Embody offers compounded semaglutide and compounded tirzepatide, both as injections. Both are pharmacy-compounded versions of the active ingredients in brand-name GLP-1 medications, and compounded drugs are not FDA-approved as finished products.
Does Embody accept insurance or HSA/FSA? Embody is cash-pay and does not bill insurance, but HSA and FSA cards are accepted. If your insurance already covers a brand-name GLP-1, going through your plan may cost less than any cash-pay program.
Is Embody legit? Embody displays a LegitScript certification seal and provides care through the OpenLoop Health network of US-licensed clinicians. Compounded medications are prepared by licensed pharmacies and are not FDA-approved as finished products, so confirm the current details on Embody's own site before enrolling.
Is Embody available in my state? Yes. Embody is available in all 50 US states.
How does Embody compare to Hims and GobyMeds? Embody's $79 Summer Start starting price undercuts GobyMeds' steady $99 and Hims' $199, but it is a promotional rate that rises with dose and plan length. GobyMeds offers flat, predictable pricing, and Hims offers brand-name semaglutide. Embody's edge is the low entry price plus an included metabolic report.